Renalytix Plc Share Price OTC Markets
Equities
RTNX.F
GB00BYWL4Y04
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.28 USD | -15.15% | -.--% | +81.70% |
05-29 | EXECUTIVE CHANGES: Resolute Mining hires former Acacia exec as chair | AN |
05-28 | Renalytix CFO Steps Down; Interim Successor Named | MT |
Sales 2024 * | 2.5M 196M | Sales 2025 * | 9.6M 753M | Capitalization | 32.41M 2.54B |
---|---|---|---|---|---|
Net income 2024 * | -33M -2.59B | Net income 2025 * | -26M -2.04B | EV / Sales 2024 * | 13 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.38 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 102 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 61.53% |
Latest transcript on Renalytix Plc
1 day | -15.15% | ||
1 month | -54.93% | ||
3 months | -54.93% | ||
6 months | -47.86% | ||
Current year | +81.70% |
Managers | Title | Age | Since |
---|---|---|---|
James McCullough
FOU | Founder | 56 | 14/03/18 |
Howard Doran
PSD | President | 63 | 31/08/23 |
Fergus Fleming
CTO | Chief Tech/Sci/R&D Officer | 57 | 14/03/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Levangie
BRD | Director/Board Member | 73 | 29/08/21 |
Chairman | 72 | 14/03/18 | |
James McCullough
FOU | Founder | 56 | 14/03/18 |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-27.52% | 16.33B | |
-40.04% | 2.96B | |
+15.16% | 1.82B | |
-6.86% | 1.55B | |
+38.67% | 1.41B | |
-15.36% | 976M | |
-26.08% | 846M | |
+3.53% | 811M | |
-24.63% | 631M |
- Stock Market
- Equities
- RENX Stock
- RTNX.F Stock